Civic Intelligence

Aim at Melanoma

990 • Fiscal year 2016 • EIN 56-2427805

Jan 01, 2016 to Dec 31, 2016 • Filed on Aug 02, 2017

Organization Profilewww.aimatmelanoma.org

View Organization Page

3040 Cutting BlvdRichmond, CA 94804

(415) 305-0060

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

14th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Liabilities / Revenue

14th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Net Margin

81st percentile

21%

Higher net margin than 81% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Top Officer Pay

81st percentile

$135,611

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 7.6% of source-year revenue.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Asset Growth

83rd percentile

22%

Faster asset growth than 83% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Revenue Growth

62nd percentile

8.0%

Faster revenue growth than 62% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets14th percentile

Assets

Up

$2,054,940

Up $374,466 (+22%) from 2015

Net Assets

Up

$2,054,940

Up $374,466 (+22%) from 2015

Liabilities

Flat

$0

Flat from 2015

Revenue And Expenses
Liabilities / Revenue14th percentileNet Margin81st percentile

Revenue

Up

$1,782,881

Up $132,226 (+8.0%) from 2015

Expenses

Up

$1,408,415

Up $138,658 (+11%) from 2015

Net Income

Down

$374,466

Down $6,432 (-1.7%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth83rd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $461,059Liabilities 2010: $2,479Net Assets 2010: $458,5802010Assets 2011: $835,775Liabilities 2011: $2,558Net Assets 2011: $833,2172011Assets 2012: $1,120,456Liabilities 2012: $0Net Assets 2012: $1,120,4562012Assets 2013: $1,182,080Liabilities 2013: $0Net Assets 2013: $1,182,0802013Assets 2014: $1,299,576Liabilities 2014: $0Net Assets 2014: $1,299,5762014Assets 2015: $1,680,474Liabilities 2015: $0Net Assets 2015: $1,680,4742015Assets 2016: $2,054,940Liabilities 2016: $0Net Assets 2016: $2,054,9402016Assets 2017: $2,398,753Liabilities 2017: $0Net Assets 2017: $2,398,7532017Assets 2018: $2,573,532Liabilities 2018: $0Net Assets 2018: $2,573,5322018Assets 2019: $3,228,161Liabilities 2019: $121,577Net Assets 2019: $3,106,5842019Assets 2020: $3,672,755Liabilities 2020: $50,000Net Assets 2020: $3,622,7552020Assets 2021: $4,688,149Liabilities 2021: $6,335Net Assets 2021: $4,681,8142021Assets 2022: $5,081,407Liabilities 2022: $8,020Net Assets 2022: $5,073,3872022Assets 2023: $6,023,375Liabilities 2023: $17,955Net Assets 2023: $6,005,4202023Assets 2024: $6,666,866Liabilities 2024: $19,708Net Assets 2024: $6,647,1582024

Highlighted filing

2016

Assets$2,054,940
Liabilities$0
Net Assets$2,054,940
Open 2016 Filing

Operations Trend

Revenue Growth62nd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0Expenses 2010: $746,3772010Expenses 2011: $871,4672011Expenses 2012: $865,7082012Revenue 2013: $1,242,832Expenses 2013: $1,181,208Net Income 2013: $61,6242013Revenue 2014: $1,322,017Expenses 2014: $1,204,521Net Income 2014: $117,4962014Revenue 2015: $1,650,655Expenses 2015: $1,269,757Net Income 2015: $380,8982015Revenue 2016: $1,782,881Expenses 2016: $1,408,415Net Income 2016: $374,4662016Revenue 2017: $2,415,270Expenses 2017: $2,071,457Net Income 2017: $343,8132017Revenue 2018: $2,544,308Expenses 2018: $2,369,528Net Income 2018: $174,7802018Revenue 2019: $2,571,648Expenses 2019: $2,037,762Net Income 2019: $533,8862019Revenue 2020: $2,335,060Expenses 2020: $1,818,889Net Income 2020: $516,1712020Revenue 2021: $2,901,257Expenses 2021: $1,842,198Net Income 2021: $1,059,0592021Revenue 2022: $2,586,311Expenses 2022: $2,194,738Net Income 2022: $391,5732022Revenue 2023: $3,245,381Expenses 2023: $2,313,348Net Income 2023: $932,0332023Revenue 2024: $2,971,089Expenses 2024: $2,329,351Net Income 2024: $641,7382024

Highlighted filing

2016

Revenue$1,782,881
Expenses$1,408,415
Net Income$374,466
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Aug 2, 2017
Return Version
2016v3.0
Gross Receipts
$1,859,117
Mission and Program Overview

Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support.The AIM at Melanoma website (www.aimatmelanoma.org) is the world's largest most comprehensive melanoma website for patients/caregivers/families. This website is viewed by 40,000 unique users per month in the US, Canada, Australia, and Europe. It serves to educate people around the globe about prevention, early detection, melanoma diagnosis, available treatments, and clinical trials.

To support melanoma research; to promote prevention and education among the general public and medical professionals; and to provide comprehensive and easily accessible melanoma resources for patients, survivors, and caregivers.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$1,680,474$2,054,940▲ $374,466
Savings and Temporary Cash Investments$978,370$1,635,367▲ $656,997
Cash and Non-Interest-Bearing Accounts$681,940$393,954▼ $287,986
Land, Buildings, and Equipment, Net$20,164$25,619▲ $5,455
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$1,680,474$2,054,940▲ $374,466
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Total Net Assets Fund Balance$1,680,474$2,054,940▲ $374,466
Total Liabilities and Net Assets / Fund Balance$1,680,474$2,054,940▲ $374,466

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$25,619$27,362$52,981
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Valerie GuildPresident and DirectorFT$130,000$5,611$135,611
Anita SchlipmannExecutive DirectorFT$120,000$5,800$125,800

Board Members and Trustees

NameTitle
Howard MaibachDirector
John KirkwoodDirector
Mohammed Kashani-sabetDirector
Renu GuptaDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$1,781,386
Program Service Revenue
$0
Investment Income
$1,495
Other Revenue
$0
All Other Contributions
$1,298,264
Change in Net Assets
$374,466
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$712,860
Salaries, Compensation, and Employee Benefits$516,055
Grants and Similar Amounts Paid$179,500
Total Fundraising Expense$134,262
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$185,800$6,000$92,924$284,724
Grants to Domestic Orgs$179,500--$179,500
Current Officers, Directors, Trustees, and Key Employees$110,500$6,500$13,000$130,000
All Other Expenses$119,682--$119,682
Other Employee Benefits$35,120$1,261$15,740$52,121
Payroll Taxes$35,136$1,476$12,598$49,210
Other Expenses$45,730--$45,730
Occupancy-$22,637-$22,637
Office Expenses-$14,720-$14,720
Fees for Services Accounting-$12,244-$12,244
Insurance$3,750--$3,750
Depreciation Depletion-$3,097-$3,097
Total Functional Expenses$1,206,218$67,935$134,262$1,408,415
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Md Anderson Cancer CenterHouston, TX-Cancer and Melanoma Research$96,000
Upmc Univ of Pittsburgh Cancer InstitutePittsburgh, PA-Cancer and Melanoma Research$65,000
Ohsu Knight Cancer InstitutePortland, OR-Cancer and Melanoma Research$18,500
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$76,236
Fundraising Gross Income$76,236
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
AIM FOR THE "CURE MELANOMA WALKS"$483,122$483,122-$483,122
Total Events$483,122$483,122-$483,122
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, line 11B

“Form 990 is submitted by the accountant to the governing body for review and discussion. The president approves the filing of form 990 based on compliance and accuracy. The accountant is then given authorization to file.”

Form 990, Part VI, Section C, line 19

“All governing documents, conflict of interest policy and applicable financial statements are available to the public upon request”

Filing and Contact Details

Filer

Filer Name
Aim at Melanoma
EIN
56-2427805
Phone
4153050060
Address
3040 CUTTING BLVD, RICHMOND, CA 94804

Signing Officer

Name
Valerie Guild
Title
President
Phone
4153050060
Signed
2017-08-02
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Valerie Guild
Formed
2004
Legal Domicile
CA
Voting Board Members
5
Independent Board Members
4
Employees
6
Volunteers
0

Preparer

Firm
Charles M Moche CPA
Address
2050 Center Avenue, Fort Lee, NJ 07024
Preparer
Charles Moche
Phone
9085611600
Supplemental Narrative

Additional Explanations

Form 990 Part XII Line 2C

“A committee assumes responsibility for the oversight of the audit, review or compilation of its financial statements and selection of its independent auditors. The organization did not change its oversight or selection process during the tax year.”

Raw XML Appendix398 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0To support melanoma research; to promote prevention and education among the general public and medical professionals; and to provide comprehensive and easily accessible melanoma resources for patients, survivors, and caregivers.
IRS990/AllOtherContributionsAmt01298264
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0119682
IRS990/AllOtherExpensesGrp/TotalAmt0119682
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0The Organization
IRS990/BooksInCareOfDetail/PhoneNum04153050060
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03040 CUTTING BLVD
IRS990/BooksInCareOfDetail/USAddress/CityNm0RICHMOND
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094804
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0681940
IRS990/CashNonInterestBearingGrp/EOYAmt0393954
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt013000
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt06500
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0110500
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0130000
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd00
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0483122
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01781386
IRS990/CYGrantsAndSimilarPaidAmt0179500
IRS990/CYInvestmentIncomeAmt01495
IRS990/CYOtherExpensesAmt0712860
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0374466
IRS990/CYSalariesCompEmpBnftPaidAmt0516055
IRS990/CYTotalExpensesAmt01408415
IRS990/CYTotalFundraisingExpenseAmt0134262
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01782881
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt03097
IRS990/DepreciationDepletionGrp/TotalAmt03097
IRS990/Desc0WEBSITEAIM at Melanoma ("AIM") is an international organization engaged in a wide variety of patient advocacy initiatives. Among these is the maintenance of the most comprehensive US website on melanoma (www.AIMatMelanoma.org). In 2016, AIM completed building its new website so it would better be able to meet the needs of the melanoma community. This included making it easier for users to locate pertinent information to assist them in better understanding their melanoma diagnosis, determining their treatment options, and understanding follow-up care. The organization continues to use various tools such as search engine optimization and distributing brochures to healthcare providers throughout the US to educate melanoma patients about the website's resources. The website is also updated regularly for medical accuracy. The US website alone, had more than 800,000 unique visitors each month.PATIENT ADVOCACYAIM provided a free nurse on call service. Throughout the year, melanoma patients, caregivers, and families reached out to AIM's oncology nurse to ask questions about, among other things, their/or their loved one's melanoma diagnosis, treatment options, and follow-up care as well as questions regarding prevention and early detection of the disease. AIM also coordinated numerous patient advocacy events, which include eight patient and caregiver symposia led by nationally recognized melanoma oncologists at major cancers such as MD Anderson, Columbia Medical Center. UCLA, and UCSF. AIM also videotaped and edited these symposiums, which were then uploaded onto YouTube so that they could be viewed by individuals in the U.S. and worldwide. AIM also provided support groups for patients, families, and survivors. AIM maintained a Facebook page, which now has over 20,000 followers and a Twitter account of over 5.600 followers in order to provide other sources of information for the melanoma community.AIM continued to represent patients on the US FDA ODAK committee, the two largest US cooperative oncology groups, SWOG and ECOG, the NCCN, and the Melanoma World Society. AIM also presented on the melanoma patient perspective at numerous meetings both in the U.S. and throughout the world.GLOBAL ADVOCACYAIM's patient advocacy was a global effort. AIM continued to host country specific, fully translated melanoma websites in Germany, France, United Kingdom, Spain, Italy, and Australia. In 2016, AIM supported and mentored patient advocacy groups in the United Kingdom, Portugal, Germany, France, Italy, Spain, Israel, Latin America, and Brazil. AIM also began its support and mentoring of additional patient advocacy groups, which included Israel and East Europe. AIM made it possible for the patient advocates to attend international melanoma meetings where they met with key opinion leaders in the melanoma community, and where they presented the patient perspective to relevant groups. AIM assisted in the development of some of their respective websites providing not only technical support but also material for the sites. AIM continued to search for additional patient advocacy groups that it could support in 2016.IMWGIn April 2006, AIM formed the International Melanoma Working Group (IMWG). The IMWG is based on the premise that melanoma requires a focused, multi-disciplinary effort among the world's leading melanoma investigators in order to provide for a better understanding of the biology of melanoma, to accelerate the quest for more effective therapies, and eventually to develop a cure for the disease. The IMWG provides a think tank atmosphere for the world's leading melanoma experts to gather away from large meetings. Since its inception, the IMWG has undertaken several key projects as a result of collaboration among its members and continues to work on additional efforts that will lead to the development of more effective treatment options for melanoma patients.IMWG members, which consist of over forty melanoma experts from throughout the world, m
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01206218
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt012244
IRS990/FeesForServicesAccountingGrp/TotalAmt012244
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt05.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt15.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt460.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt45611
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt55800
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN KIRKWOOD
IRS990/Form990PartVIISectionAGrp/PersonNm1MOHAMMED KASHANI-SABET
IRS990/Form990PartVIISectionAGrp/PersonNm2RENU GUPTA
IRS990/Form990PartVIISectionAGrp/PersonNm3HOWARD MAIBACH
IRS990/Form990PartVIISectionAGrp/PersonNm4VALERIE GUILD
IRS990/Form990PartVIISectionAGrp/PersonNm5ANITA SCHLIPMANN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4130000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5120000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4PRESIDENT AND DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0483122
IRS990/FundraisingDirectExpensesAmt076236
IRS990/FundraisingGrossIncomeAmt076236
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0179500
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0179500
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0179500
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt01859117
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt03750
IRS990/InsuranceGrp/TotalAmt03750
IRS990/InvestmentIncomeGrp/ExclusionAmt01495
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01495
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt03
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt027362
IRS990/LandBldgEquipBasisNetGrp/BOYAmt020164
IRS990/LandBldgEquipBasisNetGrp/EOYAmt025619
IRS990/LandBldgEquipCostOrOtherBssAmt052981
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0AIM AT MELANOMA IS GLOBALLY ENGAGED AND LOCALLY INVESTED IN ADVANCING THE BATTLE AGAINST MELANOMA THROUGH INNOVATIVE RESEARCH, LEGISLATIVE REFORM, EDUCATION, AND PATIENT AND CAREGIVER SUPPORT.THE AIM AT MELANOMA WEBSITE (WWW.AIMATMELANOMA.ORG) IS THE WORLD'S LARGEST MOST COMPREHENSIVE MELANOMA WEBSITE FOR PATIENTS/CAREGIVERS/FAMILIES. THIS WEBSITE IS VIEWED BY 67,000 UNIQUE USERS PER MONTH IN THE US, CANADA, AUSTRALIA, AND EUROPE. IT SERVES TO EDUCATE PEOPLE AROUND THE GLOBE ABOUT PREVENTION, EARLY DETECTION, MELANOMA DIAGNOSIS, AVAILABLE TREATMENTS, AND CLINICAL TRIALS.INNOVATION IN MELANOMA RESEARCHAIM EMPLOYS GROUNDBREAKING INTERNATIONAL RESEARCH INITIATIVES AND UNPARALLELED TOOLS AND RESOURCES IN THE BATTLE FOR THE CURE.GLOBAL ENGAGEMENT & ADVOCACYAIM MAKES A DIFFERENCE GLOBALLY THROUGH RESEARCH, EDUCATION, AND ADVOCACY EFFORTS, AND BY EFFECTING LEGISLATIVE CHANGES.Education & SupportFrom prevention, to diagnosis, to treatment, and beyond, AIM provides
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt01680474
IRS990/NetAssetsOrFundBalancesEOYAmt02054940
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt022637
IRS990/OccupancyGrp/TotalAmt022637
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt014720
IRS990/OfficeExpensesGrp/TotalAmt014720
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt015740
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt01261
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt035120
IRS990/OtherEmployeeBenefitsGrp/TotalAmt052121
IRS990/OtherExpensesGrp/Desc0PATIENT ADVOCACY
IRS990/OtherExpensesGrp/Desc1NURSE TRAINING PROGRAM
IRS990/OtherExpensesGrp/Desc2IMWG THINK TANK CONFERE
IRS990/OtherExpensesGrp/Desc3AGENCY FEES
IRS990/OtherExpensesGrp/ProgramServicesAmt0224428
IRS990/OtherExpensesGrp/ProgramServicesAmt1140250
IRS990/OtherExpensesGrp/ProgramServicesAmt2126322
IRS990/OtherExpensesGrp/ProgramServicesAmt345730
IRS990/OtherExpensesGrp/TotalAmt0224428
IRS990/OtherExpensesGrp/TotalAmt1140250
IRS990/OtherExpensesGrp/TotalAmt2126322
IRS990/OtherExpensesGrp/TotalAmt345730
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt092924
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt06000
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0185800
IRS990/OtherSalariesAndWagesGrp/TotalAmt0284724
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/FundraisingAmt012598
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt01476
IRS990/PayrollTaxesGrp/ProgramServicesAmt035136
IRS990/PayrollTaxesGrp/TotalAmt049210
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0VALERIE GUILD
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01644015
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0280000
IRS990/PYInvestmentIncomeAmt01640
IRS990/PYOtherExpensesAmt0686811
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt05000
IRS990/PYRevenuesLessExpensesAmt0380898
IRS990/PYSalariesCompEmpBnftPaidAmt0302946
IRS990/PYTotalExpensesAmt01269757
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01650655
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0374466
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt01680474
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt02054940
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0978370
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01635367
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01781386
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01644015
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01320556
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01241587
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01151011
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt07138555
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt01495
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01640
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt01462
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01245
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01936
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt07778
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt05000
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.54000
IRS990ScheduleA/PublicSupportPY170Pct00.59940
IRS990ScheduleA/PublicSupportTotal170Amt03859049
IRS990ScheduleA/SubstantialContributorsTotAmt03279506
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01781386
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01644015
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01320556
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01241587
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01151011
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt07138555
IRS990ScheduleA/TotalSupportAmt07146333
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt025619
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt027362
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt052981
IRS990ScheduleD/TotalBookValueLandBuildingsAmt025619
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0AIM FOR THE "CURE MELANOMA WALKS"
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt0483122
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt0483122
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt0483122
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt0483122
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt0483122
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt096000
IRS990ScheduleI/RecipientTable/CashGrantAmt118500
IRS990ScheduleI/RecipientTable/CashGrantAmt265000
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0MD ANDERSON CANCER CENTER
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1OHSU KNIGHT CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2UPMC UNIV OF PITTSBURGH CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientEIN0746000203
IRS990ScheduleI/RecipientTable/RecipientEIN1237083114
IRS990ScheduleI/RecipientTable/RecipientEIN2250965591
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01515 HOLCOMBE BLVD
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt11121 SW SALMON STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt25150 CENTRE AVENUE
IRS990ScheduleI/RecipientTable/USAddress/CityNm0HOUSTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PORTLAND
IRS990ScheduleI/RecipientTable/USAddress/CityNm2PITTSBURGH
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0TX
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1OR
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2PA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd077030
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd197205
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd215232
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FORM 990 IS SUBMITTED BY THE ACCOUNTANT TO THE GOVERNING BODY FOR REVIEW AND DISCUSSION. THE PRESIDENT APPROVES THE FILING OF FORM 990 BASED ON COMPLIANCE AND ACCURACY. THE ACCOUNTANT IS THEN GIVEN AUTHORIZATION TO FILE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND APPLICABLE FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2A COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT, REVIEW OR COMPILATION OF ITS FINANCIAL STATEMENTS AND SELECTION OF ITS INDEPENDENT AUDITORS. THE ORGANIZATION DID NOT CHANGE ITS OVERSIGHT OR SELECTION PROCESS DURING THE TAX YEAR.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part VI, Section B, line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section C, line 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990 PART XII LINE 2C
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt01680474
IRS990/TotalAssetsEOYAmt02054940
IRS990/TotalAssetsGrp/BOYAmt01680474
IRS990/TotalAssetsGrp/EOYAmt02054940
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt01781386
IRS990/TotalEmployeeCnt06
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt0134262
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt067935
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt01206218
IRS990/TotalFunctionalExpensesGrp/TotalAmt01408415
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt01680474
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt02054940
IRS990/TotalOtherCompensationAmt011411
IRS990/TotalProgramServiceExpensesAmt01206218
IRS990/TotalReportableCompFromOrgAmt0250000
IRS990/TotalRevenueGrp/ExclusionAmt01495
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt01782881
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt00
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt01680474
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt02054940
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt03040 CUTTING BLVD
IRS990/USAddress/CityNm0RICHMOND
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd094804
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0www.aimatmelanoma.org
IRS990/WhistleblowerPolicyInd00
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0VALERIE GUILD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum04153050060
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-08-02
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0AIM AT MELANOMA
ReturnHeader/Filer/BusinessNameControlTxt0AIMA
ReturnHeader/Filer/EIN0562427805
ReturnHeader/Filer/PhoneNum04153050060
ReturnHeader/Filer/USAddress/AddressLine1Txt03040 CUTTING BLVD
ReturnHeader/Filer/USAddress/CityNm0RICHMOND
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094804
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0DA39A3EE5E6B4B0D3255BFEF95601890AFD80709
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId06C9B1A35775087DBDB8A6D25ECA509C7F6C27838
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt054.172.10.63
ReturnHeader/FilingSecurityInformation/IPDt02017-08-02
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0ED
ReturnHeader/FilingSecurityInformation/IPTm015:45:06
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0800682248
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Charles M Moche CPA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02050 Center Avenue
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Fort Lee
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NJ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd007024
ReturnHeader/PreparerPersonGrp/PhoneNum09085611600
ReturnHeader/PreparerPersonGrp/PreparationDt02017-08-02
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Charles Moche
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02017-08-02T15:47:56-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$2,054,940
Liabilities
$0
Net assets
$2,054,940
Revenue
$1,782,881
Expenses
$1,408,415
Net income
$374,466
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$6.67$0.02$6.65$2.97$2.33$0.64
2023Detailed filing. Detailed filing data is available for this year.$6.02$0.02$6.01$3.25$2.31$0.93
2022Detailed filing. Detailed filing data is available for this year.$5.08$0.01$5.07$2.59$2.19$0.39
2021Detailed filing. Detailed filing data is available for this year.$4.69$0.01$4.68$2.90$1.84$1.06
2020Detailed filing. Detailed filing data is available for this year.$3.67$0.05$3.62$2.34$1.82$0.52
2019Detailed filing. Detailed filing data is available for this year.$3.23$0.12$3.11$2.57$2.04$0.53
2018Detailed filing. Detailed filing data is available for this year.$2.57$0.00$2.57$2.54$2.37$0.17
2017Detailed filing. Detailed filing data is available for this year.$2.40$0.00$2.40$2.42$2.07$0.34
2016Detailed filing. Detailed filing data is available for this year.$2.05$0.00$2.05$1.78$1.41$0.37
2015Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$1.65$1.27$0.38
2014Detailed filing. Detailed filing data is available for this year.$1.30$0.00$1.30$1.32$1.20$0.12
2013Detailed filing. Detailed filing data is available for this year.$1.18$0.00$1.18$1.24$1.18$0.06
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.12$0.00$1.12$0.87
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.84$0.00$0.83$0.87
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.00$0.46$0.75